J.B.Chemicals share price has zoomed 2% and is presently trading at Rs 1,827.3.
Meanwhile, the BSE HEALTHCARE index is at 37,240.5 .
Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 2.2%) and HIKAL CHEMIC (up 1.4%).
MAX HEALTHCARE INSTITUTE (down 2.5%) and METROPOLIS HEALTHCARE (down 1.1%) are among the top losers today.
Over the last one year, J.B.Chemicals has moved up from Rs 1,173.7 to Rs 1,827.3, registering a gain of Rs 653.6 (up 55.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,634.3 to 37,240.5, registering a gain of 45.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 86.6%), Cadila Healthcare (up 83.5%) and Jubilant Pharmova (up 83.2%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,569.2 (up 0.1%).
The top gainers among the BSE Sensex today are Infosys (up 1.1%) and HCl Tech. (up 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,144.9 . ONGC and Wipro are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,915.4 to 79,569.2, registering a gain of 15,653.7 points (up 24.5%).
J.B.Chemicals net profit grew 44.0% YoY to Rs 1,262 million for the quarter ended March 2024, compared to a profit of Rs 876 million a year ago. Net sales rose 13.0% to Rs 8,617 million during the period as against Rs 7,623 million in January-March 2023.
For the year ended March 2023, J.B.Chemicals reported 6.2% increase in net profit to Rs 4,100 million compared to net profit of Rs 3,860 million during FY22. Revenue of the company grew 29.9% to Rs 31,493 million during FY23.
The current Price to earnings ratio of J.B.Chemicals, based on rolling 12 month earnings, stands at 51.3.
Equitymaster requests your view! Post a comment on "J.B.Chemicals Gains 2%; BSE HEALTHCARE Index Down 0.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!